AzTrials
AzTrials

ColonoscopyNCT06407531

Before Colonoscopy Effect of Virtual Reality Application on Anxiety and Vital Signs

A study testing VR-G in people with Colonoscopy, run by Akdeniz University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study was planned to examine the effect of virtual reality application on the patient's anxiety and vital signs before colonoscopy. The hypotheses of the research are as follows: H1: Virtual reality application before colonoscopy has an effect on patients' anxiety and vital signs. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Colonoscopy
What is being tested?
VR-G
Could I receive a placebo?
No, everyone receives an active treatment
How many people
70 participants
Where
1 siteTurkey (Türkiye)
Study dates
25 Nov 2023to 1 Jul 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Volunteering to participate in the research,
  • Being literate,
  • Be 18 years or older.

Who cannot join

  • Performing colonoscopy at the same time as endoscopy,
  • Using any analgesic or anxiolytic,
  • Having a visual or hearing impairment,
  • Performing an emergency colonoscopy.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Finike State Hospital

    Antalya, Finike, 07740

Other trials in Turkey (Türkiye)

About this study

Official title: Examining the Effect of Virtual Reality Application on Patient's Anxiety and Vital Signs Before Colonoscopy: A Randomized Controlled Study

This study was planned to examine the effect of virtual reality application on the patient's anxiety and vital signs before colonoscopy. The hypotheses of the research are as follows:

H1: Virtual reality application before colonoscopy has an effect on patients' anxiety and vital signs.

H0: Virtual reality application before colonoscopy has no effect on patients' anxiety and vital signs.

Before colonoscopy, patients in the study group will be asked to watch videos using virtual reality glasses.

Read the detailed description

After obtaining the ethics committee and institutional permission for the research, the researcher was taken to the hospital for the colonoscopy procedure.

He/she will introduce himself/herself to the patients and explain the purpose of the research. Patients who volunteered to participate in the study Informed consent will be obtained. Data regarding the socio-demographic characteristics of the patients included in the patient introduction form The patient will be interviewed face to face, and data regarding the patients' clinical characteristics will be recorded from the patient file. colonoscopy Data will begin to be collected from the first patient to undergo the procedure. Anxiety and life assessment with VAS 30 minutes before the procedure The findings will be considered. According to the randomization, the patient in the virtual reality glasses group was first asked by the researcher.

It will be explained to the patient that he will wear the glasses for 30 minutes and watch a video before the procedure. By researcher 30 When the minute is up, the patient will be informed and asked to remove the glasses. No intervention was made to the patient in the control group.

It will not be done. Anxiety and vital signs were measured with VAS 5-10 minutes before the procedure began in all patient groups.

will be looked into. After each patient use, the virtual reality glasses will be cleaned and dried with alcohol-based cleaning material.

Conditions
Colonoscopy
Being tested
VR-G
Keywords
virtual reality glasses, surgical nursing, colonoscopy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • VR-GOther

    Patients watched videos with virtual glasses before undergoing colonoscopy

Study groups in NCT06407531
Study groupRoleWhat they receive
VR-GExperimentalThe patient will wear virtual glasses and watch a video 30 minutes before the procedure.
Receives: Other: VR-G
ControlNo interventionNo intervention will be performed on control group patients and the standard care protocol of the clinic will be applied.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Anxiety (Visual Analog Scale-Anxiety)

    Patients' anxiety will be evaluated (0-10 point). Grading is made with a 10 cm long horizontal or vertical ruler on the scale and "0" means no anxiety and "10" means the most severe anxiety. In the application, the patient was asked to mark the intensity of pain he felt on the ruler and the value was measured and recorded.

    Measured: 30 minutes before colonoscopy

  2. Anxiety (Visual Analog Scale-Anxiety)

    Patients' anxiety will be evaluated (0-10 point). Grading is made with a 10 cm long horizontal or vertical ruler on the scale and "0" means no anxiety and "10" means the most severe anxiety. In the application, the patient was asked to mark the intensity of pain he felt on the ruler and the value was measured and recorded.

    Measured: 5-10 minutes before colonoscopy

  3. Systolic blood pressure

    In the measurement of vital signs of individuals, devices that measure digital blood pressure will be used by applying the necessary hygiene rules at patient transitions.

    Measured: 30 minutes before colonoscopy

  4. Systolic blood pressure

    In the measurement of vital signs of individuals, devices that measure digital blood pressure will be used by applying the necessary hygiene rules at patient transitions.

    Measured: 5-10 minutes before colonoscopy

  5. Diastolic blood pressure

    In the measurement of vital signs of individuals, devices that measure digital blood pressure will be used by applying the necessary hygiene rules at patient transitions.

    Measured: 30 minutes before colonoscopy

  6. Diastolic blood pressure

    In the measurement of vital signs of individuals, devices that measure digital blood pressure will be used by applying the necessary hygiene rules at patient transitions.

    Measured: 5-10 minutes before colonoscopy

  7. Heart rate

    In the measurement of vital signs of individuals, devices that measure digital pulse will be used by applying the necessary hygiene rules at patient transitions.

    Measured: 5-10 minutes before colonoscopy

  8. Heart rate

    In the measurement of vital signs of individuals, devices that measure digital pulse will be used by applying the necessary hygiene rules at patient transitions.

    Measured: 30 minutes before colonoscopy

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 May 2024
  2. Study start25 Nov 2023
  3. Primary completion30 May 2024
  4. Study completion1 Jul 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
30 minutes before colonoscopy, the patients' systolic, diastolic blood pressure and heart rate were measured and recorded. Anxiety levels were determined with VAS. Afterwards, the patients were shown videos using virtual reality glasses. 5-10 minutes before the colonoscopy, the patients' systolic, diastolic blood pressure and heart rate were measured and recorded. Anxiety levels were determined with VAS.
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
70 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06407531
Sponsor's protocol ID
VRG208
Status last verified
Jul 2024
First submitted
3 May 2024
Last updated
18 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Yenigun Akbulut SC, Alptekin HM, Unver S. Effectiveness of Virtual Reality Intervention on Anxiety and Vital Signs of Patients Before Colonoscopy: A Randomised Controlled Study. Nurs Open. 2026 Mar;13(3):e70465. doi: 10.1002/nop2.70465.

    PubMed 41840460

Questions about this trial

What is this clinical trial studying?

A study testing VR-G in people with Colonoscopy, run by Akdeniz University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Anxiety (Visual Analog Scale-Anxiety) (time frame: 30 minutes before colonoscopy). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06407531, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in